AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that reduces CD8+ T cell exhaustion to induce potent antitumor activity

AB821 - Asher Biotherap

https://jitc.bmj.com/content/11/Suppl_1/A1155

Renee Greer; Arisa Paul; Jeffrey Houser; Audrey Hollingsworth; Wei Wei Prior; Manu Kumar; Ruth Lan; Yik Andy Yeung; Ivana Djuretic

Sep 27, 2023